General Therapeutics

General Therapeutics is a pioneering biotech company committed to transforming the future of RNA therapeutics and vaccine delivery. Our mission is to develop innovative solutions that address the limitations of current technologies, ensuring safer, more effective treatments for global health challenges. At the core of our work are our cutting-edge Ionizable lipids, non-reactogenic LNP, and QuikLNP formulation technologies, which promote the ultimate safety and accessibility of RNA medicines. Our interdisciplinary team integrates advanced lipid chemistry, computational modeling, and rigorous in vivo experimentation to drive innovation. Focused on reducing reactogenicity, EAs, and enhancing therapeutic outcomes, we aim to deliver groundbreaking RNA-based solutions for infectious diseases, oncology, and beyond. At General Therapeutics, we are committed to shaping the future of precision medicine and improving lives worldwide.